I am not inclined to defend James. I am pretty convinced that he is out of his depth. none of that changes that the pedigree of this discovery is vastly different than a typical drug. no need for prior art if you have a unique compound with a distinctly different MOA.
Ann: R327 added to WHO List of Antibacterial Products, page-15
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.5¢ |
Change
0.010(2.06%) |
Mkt cap ! $114.6M | |||
| Open | High | Low | Value | Volume |
| 48.5¢ | 51.0¢ | 48.5¢ | $1.909K | 3.908K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 15775 | 48.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 49.5¢ | 66869 | 2 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| RCE (ASX) Chart |